Literature DB >> 22684624

Butyrate enhances intestinal epithelial barrier function via up-regulation of tight junction protein Claudin-1 transcription.

Hong-Bo Wang1, Peng-Yuan Wang, Xin Wang, Yuan-Lian Wan, Yu-Cun Liu.   

Abstract

BACKGROUND: Barrier function is essential for the maintenance of normal intestinal function. Dysregulation of the intestinal barrier underlies a wide range of disorders. AIM: Previously, we found that sodium butyrate (NaB) decreased the molecular permeability of intestinal barrier in vivo model, but the mechanism by which NaB facilitated the tightness of tight junctions (TJs) in small intestinal epithelium needed further studies.
METHODS: In vitro culture of the cdx2-IEC monolayer was used to mimic barrier function. The TJs were assessed by transepithelial electrical resistance (TEER) and paracellular flux of fluorescein isothiocyanate-conjugated dextran 40,000 (FD-40), Western blot, Q-RT-PCR, and immunofluorescence. Promoter and chromatin immunoprecipitation (ChIP) assays were also done to analyze the Claudin-1 gene.
RESULTS: NaB decreased FD-40 flux, increased TEER and TJ protein Claudin-1 expression, induced ZO-1 and Occludin redistribution in cellular membrane, and reversed the damage effect after calcium (Ca(2+)) switch assay. Silencing Claudin-1 prevented protective function of NaB from enhancing intestinal barrier integrity. Further studies demonstrated that NaB increased Claudin-1 transcription by facilitating the interaction between transcription factor SP1 and a specific motif within the promoter region of Claudin-1. This SP1 binding motif was located upstream of the coding region (-138 to -76 bp) and indispensable for the transcription of Claudin-1 following NaB treatment. ChIP assay confirmed the association between SP1 and Claudin-1 promoter, and the elimination of the SP1 binding site by point mutation resulted in a significant loss of Claudin-1 transcription after NaB dealing.
CONCLUSIONS: NaB enhanced intestinal barrier function through increasing Claudin-1 transcription via facilitating the association between SP1 and Claudin-1 promoter.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22684624     DOI: 10.1007/s10620-012-2259-4

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  23 in total

1.  Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer.

Authors:  Punita Dhawan; Amar B Singh; Natasha G Deane; Yiran No; Sheng-Ru Shiou; Carl Schmidt; John Neff; M Kay Washington; R Daniel Beauchamp
Journal:  J Clin Invest       Date:  2005-06-16       Impact factor: 14.808

2.  Activation of an SP binding site is crucial for the expression of claudin 1 in rat epididymal principal cells.

Authors:  Julie Dufresne; Daniel G Cyr
Journal:  Biol Reprod       Date:  2007-01-24       Impact factor: 4.285

Review 3.  Molecular basis of the core structure of tight junctions.

Authors:  Mikio Furuse
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-01       Impact factor: 10.005

4.  Kinetics of butyrate metabolism in the normal colon and in ulcerative colitis: the effects of substrate concentration and carnitine on the β-oxidation pathway.

Authors:  V De Preter; K P Geboes; V Bulteel; G Vandermeulen; P Suenaert; P Rutgeerts; K Verbeke
Journal:  Aliment Pharmacol Ther       Date:  2011-06-26       Impact factor: 8.171

5.  Enhanced permeability of molecular weight markers and poorly bioavailable compounds across Caco-2 cell monolayers using the absorption enhancer, zonula occludens toxin.

Authors:  Donna S Cox; Sangeeta Raje; Huanling Gao; Noha N Salama; Natalie D Eddington
Journal:  Pharm Res       Date:  2002-11       Impact factor: 4.200

Review 6.  Butyrate as a differentiating agent: pharmacokinetics, analogues and current status.

Authors:  H L Newmark; J R Lupton; C W Young
Journal:  Cancer Lett       Date:  1994-04-01       Impact factor: 8.679

7.  HDAC inhibitors regulate claudin-1 expression in colon cancer cells through modulation of mRNA stability.

Authors:  M Krishnan; A B Singh; J J Smith; A Sharma; X Chen; S Eschrich; T J Yeatman; R D Beauchamp; P Dhawan
Journal:  Oncogene       Date:  2009-11-02       Impact factor: 9.867

8.  Anti-invasive activity of histone deacetylase inhibitors via the induction of Egr-1 and the modulation of tight junction-related proteins in human hepatocarcinoma cells.

Authors:  Sung Ok Kim; Byung Tae Choi; Il-Whan Choi; Jaehun Cheong; Gi-Young Kim; Taeg Kyu Kwon; Nam Deuk Kim; Yung Hyun Choi
Journal:  BMB Rep       Date:  2009-10-31       Impact factor: 4.778

9.  Traumatic brain injury and intestinal dysfunction: uncovering the neuro-enteric axis.

Authors:  Vishal Bansal; Todd Costantini; Lauren Kroll; Carrie Peterson; William Loomis; Brian Eliceiri; Andrew Baird; Paul Wolf; Raul Coimbra
Journal:  J Neurotrauma       Date:  2009-08       Impact factor: 5.269

10.  Claudin-1 and -2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin.

Authors:  M Furuse; K Fujita; T Hiiragi; K Fujimoto; S Tsukita
Journal:  J Cell Biol       Date:  1998-06-29       Impact factor: 10.539

View more
  188 in total

1.  Microbial Metabolites as Molecular Mediators of Host-Microbe Symbiosis in Colorectal Cancer.

Authors:  N P Hyland; A Houston; J M Keane; S A Joyce; C G M Gahan
Journal:  Results Probl Cell Differ       Date:  2020

2.  Effects of supplemental calcium and vitamin D on tight-junction proteins and mucin-12 expression in the normal rectal mucosa of colorectal adenoma patients.

Authors:  Hannah B Mandle; Ferdous A Jahan; Roberd M Bostick; John A Baron; Elizabeth L Barry; Rami Yacoub; Julia Merrill; Robin E Rutherford; March E Seabrook; Veronika Fedirko
Journal:  Mol Carcinog       Date:  2019-04-02       Impact factor: 4.784

3.  T84 monolayers are superior to Caco-2 as a model system of colonocytes.

Authors:  Sarah Devriese; Lien Van den Bossche; Sophie Van Welden; Tom Holvoet; Iris Pinheiro; Pieter Hindryckx; Martine De Vos; Debby Laukens
Journal:  Histochem Cell Biol       Date:  2017-03-06       Impact factor: 4.304

4.  Fucoidan enhances intestinal barrier function by upregulating the expression of claudin-1.

Authors:  Atsushi Iraha; Hiroshi Chinen; Akira Hokama; Takumi Yonashiro; Tetsu Kinjo; Kazuto Kishimoto; Manabu Nakamoto; Tetsuo Hirata; Nagisa Kinjo; Futoshi Higa; Masao Tateyama; Fukunori Kinjo; Jiro Fujita
Journal:  World J Gastroenterol       Date:  2013-09-07       Impact factor: 5.742

Review 5.  Microbiota: a novel regulator of pain.

Authors:  Manon Defaye; Sandie Gervason; Christophe Altier; Jean-Yves Berthon; Denis Ardid; Edith Filaire; Frédéric Antonio Carvalho
Journal:  J Neural Transm (Vienna)       Date:  2019-09-24       Impact factor: 3.575

Review 6.  [Gut-heart axis : How gut bacteria influence cardiovascular diseases].

Authors:  Hendrik Bartolomaeus; Victoria McParland; Nicola Wilck
Journal:  Herz       Date:  2020-04       Impact factor: 1.443

Review 7.  Manipulation of intestinal microbiome as potential treatment for insulin resistance and type 2 diabetes.

Authors:  Yasaman Ghorbani; Katherine J P Schwenger; Johane P Allard
Journal:  Eur J Nutr       Date:  2021-03-02       Impact factor: 5.614

8.  Sodium butyrate protects the intestinal barrier function in peritonitic mice.

Authors:  Xiaofeng Han; Huimin Song; Yunlei Wang; Yingmo Sheng; Jie Chen
Journal:  Int J Clin Exp Med       Date:  2015-03-15

9.  Butyrate reduces high-fat diet-induced metabolic alterations, hepatic steatosis and pancreatic beta cell and intestinal barrier dysfunctions in prediabetic mice.

Authors:  V A Matheus; Lcs Monteiro; R B Oliveira; D A Maschio; C B Collares-Buzato
Journal:  Exp Biol Med (Maywood)       Date:  2017-05-15

10.  Effect of individual SCFA on the epithelial barrier of sheep rumen under physiological and acidotic luminal pH conditions.

Authors:  Gabriele Greco; Franziska Hagen; Svenja Meißner; Zanming Shen; Zhongyan Lu; Salah Amasheh; Jörg R Aschenbach
Journal:  J Anim Sci       Date:  2018-02-15       Impact factor: 3.159

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.